{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:51:35Z","timestamp":1767135095570,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd008591.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000}}],"reference-count":72,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008591.pub3","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T09:51:21Z","timestamp":1614851481000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Second-generation antidepressants for treatment of seasonal affective disorder"],"prefix":"10.1002","volume":"2021","author":[{"given":"Barbara","family":"Nussbaumer-Streit","sequence":"additional","affiliation":[{"name":"Cochrane Austria, Department for Evidence-based Medicine and Evaluation; Danube University Krems; Krems Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kylie","family":"Thaler","sequence":"additional","affiliation":[{"name":"Cochrane Austria, Department for Evidence-based Medicine and Evaluation; Danube University Krems; Krems Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Chapman","sequence":"additional","affiliation":[{"name":"Cochrane Austria, Department for Evidence-based Medicine and Evaluation; Danube University Krems; Krems Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Probst","sequence":"additional","affiliation":[{"name":"Department for Psychotherapy and Psychosocial Health; Danube University Krems; Krems Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Winkler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy; Medical University of Vienna; Vienna Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"S\u00f6nnichsen","sequence":"additional","affiliation":[{"name":"Department of General Practice and Family Medicine; Medical University of Vienna; Vienna Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley N","family":"Gaynes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA"},{"name":"Department of Epidemiology, Gillings Global School of Public Health; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Gartlehner","sequence":"additional","affiliation":[{"name":"Cochrane Austria, Department for Evidence-based Medicine and Evaluation; Danube University Krems; Krems Austria"},{"name":"RTI International; Research Triangle Park North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD008591.pub3-BIB0001|cit1","first-page":"252","article-title":"The efficacy of bupropion in winter depression: results of an open trial","volume":"53","author":"Dilsaver","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD008591.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1176\/ajp.152.12.1765","article-title":"Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder","volume":"152","author":"Lam","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/628434","article-title":"Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine","volume":"628434","author":"Cheung","year":"2012","journal-title":"Depression Research and Treatment"},{"issue":"1-3","key":"10.1002\/14651858.CD008591.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jad.2006.01.030","article-title":"Personality and seasonal affective disorder: results from the CAN-SAD study","volume":"93","author":"Enns","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008591.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/ajp.2006.163.5.805","article-title":"The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder","volume":"163","author":"Lam","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008591.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1017\/S0033291706009378","article-title":"Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the CAN-SAD study","volume":"37","author":"Michalak","year":"2007","journal-title":"Psychological Medicine"},{"issue":"2-3","key":"10.1002\/14651858.CD008591.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jad.2005.10.010","article-title":"O sweet spot where art thou? Light treatment of Seasonal Affective Disorder and the circadian time of sleep","volume":"90","author":"Murray","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008591.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/07420520500263292","article-title":"Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?","volume":"22","author":"Murray","year":"2005","journal-title":"Chronobiology International"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1016\/S0924-977X(09)70624-8","article-title":"Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine","volume":"19 Suppl 3","author":"Pjrek","year":"2009","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2007-958718","article-title":"Escitalopram in seasonal affective disorder: results of an open trial","volume":"40","author":"Pjrek","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008591.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/s-2008-1058103","article-title":"Treatment of seasonal affective disorder with duloxetine: an open-label study","volume":"41","author":"Pjrek","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-977X(00)00114-0","article-title":"Reboxetine in seasonal affective disorder: an open trial","volume":"11","author":"Hilger","year":"2001","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1016\/S0924-977X(09)70624-8","article-title":"Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine","volume":"19 Suppl 3","author":"Pjrek","year":"2009","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpsychires.2008.11.004","article-title":"Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis","volume":"43","author":"Pjrek","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2007-958718","article-title":"Escitalopram in seasonal affective disorder: results of an open trial","volume":"40","author":"Pjrek","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1017\/S0033291798006813","article-title":"Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder","volume":"28","author":"Ruhrmann","year":"1998","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0017|cit17","first-page":"193","article-title":"Fluoxetine as a treatment alternative to light therapy in seasonal affective disorder (SAD) [abstract]","volume":"26","author":"Ruhrmann","year":"1993","journal-title":"Pharmacopsychiatry [abstracts from the 18th Symposium of AGNP, Nuremberg 1993]"},{"issue":"Suppl 1, Pt B","key":"10.1002\/14651858.CD008591.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002826-199202001-00660","article-title":"Selective serotonin re-uptake inhibitors for treatment of seasonal affective disorder (SAD) [poster abstract]","volume":"15","author":"Ruhrmann","year":"1992","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0019|cit19","first-page":"11","article-title":"The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses","volume":"30","author":"Shen","year":"2005","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0020|cit20","unstructured":"A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300 mg\/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-Week observational follow-up phase www.gsk-clinicalstudyregister.com"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0021|cit21","unstructured":"A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300 mg\/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up phase www.gsk-clinicalstudyregister.com"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0022|cit22","unstructured":"A 7-month, multicenter, randomized, double-blind, placebo-controlled comparison of 150-300 mg\/day of extended-release bupropion hydrochloride (WELLBUTRIN XL) and placebo for the prevention of seasonal affective disorder in subjects with a history of seasonal affective disorder followed by an 8-week observational follow-up study www.gsk-clinicalstudyregister.com"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0023|cit23","unstructured":"Blashko C A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder 8th ECNP (European College of Neuropsychopharmacology) Congress; 1995 09 30 - 10 04; Venice, Italy Venice, Italy European College of Neuropsychopharmacology 1995"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0024|cit24","unstructured":"Blashko C Drug treatment of winter depression: How effective is it, and what can it tell us about the biology of SAD? Sixth World Congress of Biological Psychiatry; 1997 06 22-27, Nice, France Nice, France World Federation of the Societies of Biological Psychiatry 1997"},{"issue":"4","key":"10.1002\/14651858.CD008591.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00213-003-1594-8","article-title":"A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder","volume":"171","author":"Moscovitch","year":"2004","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD008591.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0327(96)00073-0","article-title":"Moclobemide and fluoxetine in treatment of seasonal affective disorder","volume":"41","author":"Partonen","year":"1996","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1002\/14651858.CD008591.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0033-1353171","article-title":"An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features","volume":"46","author":"Seo","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0028|cit28","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (Text Revision)","author":"American Psychiatric Association","year":"2000"},{"issue":"3","key":"10.1002\/14651858.CD008591.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1503\/cmaj.081514","article-title":"Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies","volume":"180","author":"Barbui","year":"2009","journal-title":"CMAJ: Canadian Medical Association Journal\/Journal de l'Association Medicale Canadienne"},{"issue":"2","key":"10.1002\/14651858.CD008591.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jsmc.2008.01.012","article-title":"Seasonal affective disorder and light therapy","volume":"3","author":"Byrne","year":"2008","journal-title":"Sleep Medicine Clinics"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuroscience.2011.09.036","article-title":"Interactions of the serotonin and circadian systems: nature and nurture in rhythms and blues","volume":"197","author":"Ciarleglio","year":"2011","journal-title":"Neuroscience"},{"issue":"10128","key":"10.1002\/14651858.CD008591.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0033|cit33","unstructured":"Covidence systematic review software Veritas Health Innovation 2019"},{"issue":"27","key":"10.1002\/14651858.CD008591.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0035|cit35","volume-title":"S3-Leitlinie\/Nationale Versorgungs-Leitlinie Unipolare Depression - Langfassung [S3-Guideline\/National Guideline on unipolar depression - long version]","year":"2015"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0036|cit36","unstructured":"Gartlehner G Morgan LC Thieda P Thaler K Hansen RA Gaynes B Drug class review: Second generation antidepressants [Drug Effectiveness Review Project (DERP) report] Oregon, USA Oregon Health & Science University"},{"issue":"11","key":"10.1002\/14651858.CD008591.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis","volume":"155","author":"Gartlehner","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"e014912","DOI":"10.1136\/bmjopen-2016-014912","article-title":"Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews","volume":"7","author":"Titscher","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD008591.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1176\/appi.ajp.162.4.656","article-title":"The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence","volume":"162","author":"Golden","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD008591.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3389\/fpsyt.2020.00599","article-title":"Nature and nurture: effects of affective temperaments on depressive symptoms are markedly modified by stress exposure","volume":"30","author":"Gonda","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0041|cit41","volume-title":"Manual for the ECDEU Assessment Battery","author":"Guy","year":"1970"},{"issue":"4","key":"10.1002\/14651858.CD008591.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD008591.pub3-BIB0043|cit43","first-page":"21","article-title":"Rating depressive patients","volume":"41","author":"Hamilton","year":"1980","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0272989X08323298","article-title":"Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose","volume":"29","author":"Hansen","year":"2009","journal-title":"Medical Decision Making"},{"issue":"9791","key":"10.1002\/14651858.CD008591.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(11)60095-0","article-title":"Novel melatonin-based therapies: potential advances in the treatment of major depression","volume":"378","author":"Hickie","year":"2011","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0046|cit46","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009 Available from training.cochrane.org\/handbook\/archive\/v5.0.2\/"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008591.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1177\/070674372001460101004","article-title":"Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments","volume":"46","author":"Kennedy","year":"2001","journal-title":"Canadian Journal of Psychiatry\/Revue Canadienne de Psychiatrie"},{"issue":"9207","key":"10.1002\/14651858.CD008591.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.podrm.2015.12.001","article-title":"Bupropion hydrochloride","volume":"41","author":"Khan","year":"2016","journal-title":"Profiles of Drug Substances, Excipients and Related Methodology"},{"issue":"3","key":"10.1002\/14651858.CD008591.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.31887\/DCNS.2007.9.3\/rlevitan","article-title":"The chronobiology and neurobiology of winter seasonal affective disorder","volume":"9","author":"Levitan","year":"2007","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD008591.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/070674370004500708","article-title":"Estimated prevalence of the seasonal subtype of major depression in a Canadian community sample","volume":"45","author":"Levitt","year":"2000","journal-title":"Canadian Journal of Psychiatry\/Revue Canadienne de Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD008591.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/070674370204700407","article-title":"The impact of latitude on the prevalence of seasonal depression","volume":"47","author":"Levitt","year":"2002","journal-title":"Canadian Journal of Psychiatry\/Revue Canadienne de Psychiatrie"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","year":"2021","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD008591.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0165-0327(00)00320-7","article-title":"Treatment compliance in light therapy: do patients do as they say they do?","volume":"68","author":"Michalak","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jad.2018.04.040","article-title":"The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: a Bayesian meta-analysis of Food and Drug Administration reviews","volume":"235","author":"Monden","year":"2018","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1017\/S1461145701002644","article-title":"Monoaminergic function in the pathogenesis of seasonal affective disorder","volume":"4","author":"Neumeister","year":"2001","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0058|cit58","unstructured":"National Institute for Health and Care Excellence (NICE) Depression in adults: recognition and managment, Clinical guideline [CG90] www.nice.org.uk\/guidance\/cg90\/chapter\/1-Guidance#care-of-all-people-with-depression"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-018-1951-0","article-title":"Implementing prevention of seasonal affective disorder from patients\u2019 and physicians\u2019 perspectives - a qualitative study","volume":"18","author":"Nussbaumer-Streit","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0060|cit60","volume-title":"Seasonal affective disorder: do non-medical treatments like light therapy and vitamin therapy lead to better results? [Original title of the health techonolgy\u00a0assessment:\u00a0Herbst-Winter-Depression F\u00fchren nicht medikament\u00f6se Verfahren wie Licht- und Vitamin","author":"Nussbaumer-Streit","year":"2020"},{"issue":"3","key":"10.1002\/14651858.CD008591.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/07420528.2013.833935","article-title":"Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system","volume":"31","author":"Oldham","year":"2014","journal-title":"Chronobiology International"},{"issue":"8","key":"10.1002\/14651858.CD008591.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpsychires.2008.11.004","article-title":"Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis","volume":"43","author":"Pjrek","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000502891","article-title":"The efficacy of light therapy in the treatment of seasonal affective disorder: a meta-analysis of randomized controlled trials","volume":"89","author":"Pjrek","year":"2020","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD008591.pub3-BIB0064|cit64","unstructured":"Review Manager (RevMan) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archpsyc.1984.01790120076010","article-title":"Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy","volume":"41","author":"Rosenthal","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD008591.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S109285290001960X","article-title":"Update on the biology of seasonal affective disorder","volume":"10","author":"Sohn","year":"2005","journal-title":"CNS Spectrums"},{"issue":"1","key":"10.1002\/14651858.CD008591.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2017.11.056","article-title":"Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: a systematic review and network meta-analysis","volume":"228","author":"Wagner","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1002\/14651858.CD008591.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"8","key":"10.1002\/14651858.CD008591.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008591.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00406-018-0921-3","article-title":"Prevalence of seasonal depression in a prospective cohort study","volume":"269","author":"Wirz-Justice","year":"2018","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD008591.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008591","article-title":"Second-generation antidepressants for seasonal affective disorder (SAD)","author":"Thaler","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD008591.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008591.pub2","article-title":"Second-generation antidepressants for seasonal affective disorder","author":"Thaler","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T06:35:06Z","timestamp":1724567706000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008591.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008591.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]}}}